2,182 Followers on Owler
OverviewCompetitorsAcquisitionsFundingNews & Insights

Apellis Competitors or Alternatives

Apellis's top competitors include Amgen, Novartis and Astellas.

Unlock 23 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

Apellis's company profile

Cedric Francois

President & CEO

86/100
733
$865.5M
$1.1B
  • $865.5M
    $1.1B
  • 733
    $865.5M
  • $1.1B
  • 86/100
  • 733
  • $865.5M
  • $1.1B
View ProfileView
1
Apellis's Competitor - Amgen logo

Robert A. Bradway

Chairman & CEO

68/100
25,200
$4.1B
$38.1B
  • $4.1B
    $38.1B
  • 25,200
    $4.1B
  • $38.1B
  • 68/100
  • 25,200
  • $4.1B
  • $38.1B
View ProfileView
2
Apellis's Competitor - Novartis logo

Vasant Narasimhan

CEO

79/100
77,052
$11B
$54.8B
  • $11B
    $54.8B
  • 77,052
    $11B
  • $54.8B
  • 79/100
  • 77,052
  • $11B
  • $54.8B
View ProfileView
3
Apellis's Competitor - Astellas logo

Naoki Okamura

President & CEO

53/100
14,754
- -
$10.9B
  • - -
    $10.9B
  • 14,754
    - -
  • $10.9B
  • 53/100
  • 14,754
  • - -
  • $10.9B
View ProfileView
4
Apellis's Competitor - Johnson & Johnson logo

Joaquin Duato

Chairman & CEO

71/100
152,700
- -
$97.9B
  • - -
    $97.9B
  • 152,700
    - -
  • $97.9B
  • 71/100
  • 152,700
  • - -
  • $97.9B
View ProfileView
5
Apellis's Competitor - Alkeus logo

Michel Dahan

President & CEO

90/100
1 - 25
$150M
$100K - 5M
  • $150M
    $100K - 5M
  • 1 - 25
    $150M
  • $100K - 5M
  • 90/100
  • 1 - 25
  • $150M
  • $100K - 5M
View ProfileView
Apellis' top 26 competitors are Amgen, Novartis, Astellas, Alexion, Johnson & Johnson, Alkeus, IVERIC Bio, Gyroscope, Lineage Cell Therapeutics, Alnylam, Akari Therapeutics, Regeneron, BioCryst, Amyndas Pharmaceuticals, BeiGene, Jnana, BioAtla, The Medicines Company, Rigel Pharmaceuticals, Agile Therapeutics, Kymab, Principia Biopharma, Inc., Immunophotonics, Tilos Therapeutics, Inc., Paragon Gene and Genmab. Together they have raised over 31.0B between their estimated 304.1K employees. Apellis has 733 employees and is ranked lowest among it's top 10 competitors. The top 10 competitors average 11,726.

Apellis VS Amgen

Amgen is the top competitor of Apellis. Amgen is a Public company that was founded in Thousand Oaks, California in 1980. Like Apellis, Amgen also operates in the Pharmaceuticals sector. Amgen has 24,467 more employees vs. Apellis.

Apellis VS Novartis

Novartis is seen as one of Apellis's biggest rivals. Novartis was founded in Basel, Basel-City} in 1996. Like Apellis, Novartis also competes in the Pharmaceuticals space. Compared to Apellis, Novartis generates $53.7B more revenue.

Apellis VS Astellas

Astellas is perceived as one of Apellis's biggest rivals. Astellas was founded in 2005, and is headquartered in Tokyo, Tōkyō Prefecture. Like Apellis, Astellas also operates in the Pharmaceuticals space. Astellas generates $9.8B more revenue vs. Apellis.

Looking for similar companies to Apellis?

Similar Companies

Companies in Waltham with revenue in $1.0-5.0B range

See 11 companies 
Pharmaceuticals companies in Waltham

See 36 companies 
Companies in Waltham with employees in 500-1.0K range

See 22 companies 
Biotechnology companies with revenue in $1.0-5.0B range

See 59 companies 
Biotechnology companies in Waltham

See 99 companies 
Pharmaceuticals & Biotechnology companies in Waltham

See 123 companies 
Pharmaceuticals companies with revenue in $1.0-5.0B range

See 154 companies 
Companies in Massachusetts with revenue in $1.0-5.0B range

See 178 companies 
Companies in Greater Boston with revenue in $1.0-5.0B range

See 178 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for Apellis and Apellis's Competitors

September 5, 2026Quartz
Novartis paused 8 trials of its rap-cel therapy after patients died from a severe immune reaction; Bristol Myers followed as a precaution...
September 4, 2026Benzinga
The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN ) common stock...
September 4, 2026Openpr
Biopharmaceuticals Market Overview: The global biopharmaceuticals market is projected to grow at a compound annual growth rate (CAGR) of approximately ...

Frequently Asked Questions about Apellis

  1. Who are Apellis's top competitors?

    Apellis's top 3 competitors are Amgen, Novartis, Astellas.

  2. Who is similar to Apellis?

    Amgen is the most similar to Apellis. Novartis and Astellas are also similar to Apellis.

  1. Are Apellis and Amgen competitors?

    Yes, Amgen is one of Apellis’s top competitors.